Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 511,357 |
|
|||||
| News | - | ||||||
| Day High | 4.51 | Low High |
|||||
| Day Low | 4.23 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Inozyme Pharma Inc | INZY | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.11 | 2.54% | 4.44 | 23:00:11 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.33 | 4.23 | 4.51 | 4.44 | 4.33 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,194 | 511,357 | US$ 4.44 | US$ 2,271,495 | - | 2.689 - 7.795 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:20:01 | formt | 390 | US$ 4.44 | USD |
Inozyme Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 274.27M | 61.77M | - | 0 | -71.17M | -1.15 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Inozyme Pharma News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INZY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.54 | 4.63 | 4.18 | 4.40 | 650,641 | -0.10 | -2.20% |
| 1 Month | 7.66 | 7.795 | 4.18 | 5.51 | 864,480 | -3.22 | -42.04% |
| 3 Months | 5.56 | 7.795 | 4.18 | 5.89 | 696,682 | -1.12 | -20.14% |
| 6 Months | 2.90 | 7.795 | 2.689 | 5.13 | 547,298 | 1.54 | 53.10% |
| 1 Year | 5.68 | 7.795 | 2.689 | 5.17 | 574,035 | -1.24 | -21.83% |
| 3 Years | 19.01 | 19.58 | 0.991 | 4.63 | 405,656 | -14.57 | -76.64% |
| 5 Years | 17.93 | 31.6499 | 0.991 | 5.37 | 337,976 | -13.49 | -75.24% |
Inozyme Pharma Description
| Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, or genetically engineered, fusion protein that is designed to correct a defect in the mineralization pathway caused by ENPP1 and ABCC6 deficiencies. |
